Supplementary Methods and Materials from Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target

Open Access

Publisher Website

30 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/0008-5472.22370924.v1

Abstract

No abstract available

Keywords